Incidence and survival for merkel cell carcinoma in Queensland, Australia, 1993-2010

JAMA Dermatology

Volumn 150, Issue 8, 2014, Pages 864-872

  Youlden, Danny R ^a   Soyer, H Peter ^b   Youl, Philippa H ^a   Fritschi, Lin ^c   Baade, Peter D ^a  

^a CANCER COUNCIL QUEENSLAND   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 20;

ADOLESCENT; ADULT; AGED; ARTICLE; AUSTRALIA; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER SURVIVAL; CAUSE SPECIFIC SURVIVAL; CHILD; COHORT ANALYSIS; DISTANT METASTASIS; FEMALE; HAZARD RATIO; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MERKEL CELL TUMOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, MERKEL CELL; CHILD; CHILD, PRESCHOOL; EAR NEOPLASMS; FACIAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; INFANT; LOWER EXTREMITY; MALE; MIDDLE AGED; QUEENSLAND; REGISTRIES; RETROSPECTIVE STUDIES; SEX FACTORS; SKIN NEOPLASMS; SURVIVAL RATE; TORSO; YOUNG ADULT;

EID: 84906751899     PISSN: 21686068     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamadermatol.2014.124     Document Type: Article

References (42)

1. Toker C. Trabecular carcinoma of the skin. Arch Dermatol. 1972;105(1):107-110.
2. Wang TS, Byrne PJ, Jacobs LK, Taube JM. Merkel cell carcinoma. Semin Cutan Med Surg. 2011;30(1):48-56.
3. Maksimovic S, Baba Y, Lumpkin EA. Neurotransmitters and synaptic components in the Merkel cell-neurite complex, a gentle-touch receptor. Ann N Y Acad Sci. 2013;1279:13-21.
4. Pulitzer MP, Amin BD, Busam KJ. Merkel cell carcinoma. Adv Anat Pathol. 2009;16(3):135-144.
5. Becker JC. Merkel cell carcinoma. Ann Oncol. 2010;21(suppl 7):vii81-vii85.
6. Taylor G, Mollick DK, Heilman ER. Merkel cell carcinoma. In: Rigel DS, Friedman RJ, Dzubow LM, Reintgen DS, Bystryn J, Marks R, eds. Cancer of the Skin. Philadelphia, PA: Elsevier Saunders; 2005.
7. Jalilian C, Chamberlain AJ, Haskett M, et al. Clinical and dermoscopic characteristics of Merkel cell carcinoma. Br J Dermatol. 2013;169(2):294-297.
8. Nicolaidou E, Mikrova A, Antoniou C, Katsambas AD. Advances in Merkel cell carcinoma pathogenesis and management. Br J Dermatol. 2012;166(1):16-21.
9. Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science. 2008;319(5866):1096-1100. (Pubitemid 351300792)
10. Schrama D, Ugurel S, Becker JC. Merkel cell carcinoma. Curr Opin Oncol. 2012;24(2):141-149.
11. Prieto Muñoz I, Pardo Masferrer J, Olivera Vegas J, Medina Montalvo MS, Jover Díaz R, Pérez Casas AM. Merkel cell carcinoma from 2008 to 2012. Cancer Treat Rev. 2013;39(5):421-429.
12. Stenbeck KD, Balanda KP, Williams MJ, et al. Patterns of treated non-melanoma skin cancer in Queensland, the region with the highest incidence rates in the world. Med J Aust. 1990;153(9):511-515. (Pubitemid 20387411)
13. Coory M, Baade P, Aitken J, Smithers M, McLeod GR, Ring I. Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002. Cancer Causes Control. 2006;17(1):21-27. (Pubitemid 43083666)
14. Leiter U, Garbe C. Epidemiology of melanoma and nonmelanoma skin cancer. Adv Exp Med Biol. 2008;624:89-103.
15. Girschik J, Thorn K, Beer TW, Heenan PJ, Fritschi L. Merkel cell carcinoma inWestern Australia. Br J Dermatol. 2011;165(5):1051-1057.
16. Australian Bureau of Statistics. Statistical Geography. Vol 1: Canberra, ACT, Australia: ABS; 2006.
17. Lemos BD, Storer BE, Iyer JG, et al. Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma. J AmAcad Dermatol. 2010;63(5):751-761.
18. Calder KB, Coplowitz S, Schlauder S, Morgan MB. A case series and immunophenotypic analysis of CK20-/CK7+ primary neuroendocrine carcinoma of the skin. J Cutan Pathol. 2007;34(12):918-923. (Pubitemid 350132010)
19. Australian Bureau of Statistics. 3101.0-Australian Demographic Statistics, Dec 2011. http://www.abs.gov.au/AUSSTATS/absat.nsf/ allprimarymainfeatures/81C5AE743DDCF8F0CA257A850013DF4C?opendocument. Accessed April 3, 2014.
20. Albores-Saavedra J, Batich K, Chable-Montero F, Sagy N, Schwartz AM, Henson DE. Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases. J Cutan Pathol. 2010;37(1):20-27.
21. United States Census Bureau. US Standard Population, 1940-2000. http://seer.cancer.gov/stdpopulations/stdpop.19ages.html. Accessed June 3, 2013.
22. Kegler SR. Applying the compound Poisson process model to the reporting of injury-related mortality rates. Epidemiol Perspect Innov. 2007;4:1.
23. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335-351. (Pubitemid 30070608)
24. Schemper M, Smith TL. A note on quantifying follow-up in studies of failure time. Control Clin Trials. 1996;17(4):343-346. (Pubitemid 26342716)
25. Brenner H, Gefeller O, Hakulinen T. Period analysis for 'up-to-date' cancer survival data. Eur J Cancer. 2004;40(3):326-335.
26. Australian Bureau of Statistics. 3302.0-Deaths, Australia, 2011. http://www.abs.gov.au/AUSSTATS/absat.nsf/Lookup/3302.0Main+Features12011. Accessed April 2, 2014.
27. Ederer F, Axtell LM, Cutler SJ. The relative survival rate. Natl Cancer Inst Monogr. 1961;6:101-121.
28. Dickman PW, Sloggett A, Hills M, Hakulinen T. Regression models for relative survival. Stat Med. 2004;23(1):51-64. (Pubitemid 38072106)
29. Kaae J, Hansen AV, Biggar RJ, et al. Merkel cell carcinoma. J Natl Cancer Inst. 2010;102(11):793-801.
30. Hussain SK, Sundquist J, Hemminki K. Incidence trends of squamous cell and rare skin cancers in the Swedish national cancer registry point to calendar year and age-dependent increases. J Invest Dermatol. 2010;130(5):1323-1328.
31. Reichgelt BA, Visser O. Epidemiology and survival of Merkel cell carcinoma in the Netherlands. Eur J Cancer. 2011;47(4):579-585.
32. Kukko H, Böhling T, Koljonen V, et al. Merkel cell carcinoma. Eur J Cancer. 2012;48(5):737-742.
33. Neale RE, Hamilton AR, Janda M, Gies P, Green AC. Seasonal variation in measured solar ultraviolet radiation exposure of adults in subtropical Australia. Photochem Photobiol. 2010;86(2):445-448.
34. Agelli M, Clegg LX. Epidemiology of primary Merkel cell carcinoma in the United States. J Am Acad Dermatol. 2003;49(5):832-841. (Pubitemid 37314870)
35. Hodgson NC. Merkel cell carcinoma. J Surg Oncol. 2005;89(1):1-4.
36. Queensland Cancer Registry, Cancer Council Queensland, Queensland Health. Cancer in Queensland, 1982-2010. Brisbane, Queensland, Australia: CCQ; 2013.
37. Youl PH, Youlden DR, Baade PD. Changes in the site distribution of common melanoma subtypes in Queensland, Australia over time. Br J Dermatol. 2013;168(1):136-144.
38. Sarfati D, Blakely T, Pearce N. Measuring cancer survival in populations. Int J Epidemiol. 2010;39(2):598-610.
39. Andea AA, Coit DG, Amin B, Busam KJ. Merkel cell carcinoma. Cancer. 2008;113(9):2549-2558.
40. Argenyi ZB. Neural and neuroendocrine neoplasms (other than neurofibromatosis). In: Bolognia JL, Jorizzo JL, Schaffer JV, eds. Dermatology. 3rd ed. Philadelphia, PA: Elsevier Saunders; 2012.
41. Miller SJ, Alam M, Andersen J, et al NCCN Merkel Cell Carcinoma Panel. Merkel cell carcinoma. J Natl Compr Canc Netw. 2009;7(3):322-332.
42. Boccara O, Girard C, Mortier L, Bens G, Saiag P, Guillot B; Cutaneous Oncology Group of the French Society of Dermatology. Guidelines for the diagnosis and treatment of Merkel cell carcinoma. Eur J Dermatol. 2012;22(3):375-379.